Fosamax and Hearing loss - a phase IV clinical study of FDA data
Summary:
We study 102,220 people who have side effects when taking Fosamax. Hearing loss is found, especially among people who are female, 60+ old, have been taking the drug for 2 - 5 years, also take Alendronate sodium and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Fosamax and have Hearing loss. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
102,220 people reported to have side effects when taking Fosamax.
Among them, 820 people (0.8%) have Hearing loss.
What is Fosamax?
Fosamax has active ingredients of alendronate sodium. It is used in osteoporosis. Currently, eHealthMe is studying from 103,235 Fosamax users.
What is Hearing loss?
Hearing loss is found to be associated with 2,456 drugs and 2,264 conditions by eHealthMe. Currently, we are studying 28,564 people who have Hearing loss.
Number of Fosamax and Hearing loss reports submitted per year:
Time on Fosamax when people have Hearing loss *:
Gender of people who have Hearing loss when taking Fosamax*:
Age of people who have Hearing loss when taking Fosamax *:
Common drugs people take besides Fosamax *:
Common side effects people have besides Hearing loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Fosamax and have Hearing loss?
Check whether Hearing loss is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Related studies
Fosamax side effects by duration, gender and age:
- Fosamax side effects (103,235 reports)
Hearing loss treatments and more:
- Hearing loss (28,564 reports)
Common drugs associated with Hearing loss:
- Humira: 1,698 reports
- Aspirin: 1,447 reports
- Methotrexate: 1,257 reports
- Prednisone: 1,122 reports
- Enbrel: 982 reports
- Fosamax: 820 reports
- Omeprazole: 688 reports
- Lyrica: 680 reports
- Lipitor: 670 reports
- Zometa: 601 reports
All the drugs that are associated with Hearing loss:
- Hearing loss (2,456 drugs)
Common conditions associated with Hearing loss:
- Rheumatoid arthritis: 1,813 reports
- High blood pressure: 1,232 reports
- Multiple sclerosis: 1,091 reports
- Osteoporosis: 899 reports
- Pain: 847 reports
All the conditions that are associated with Hearing loss:
- Hearing loss (2,264 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Fosamax) and Fosamax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fluticasone Propionate and Addison'S Disease - 14 seconds ago
- Rituxan and Ulcerative Colitis - 16 seconds ago
- Chondroitin Sulfate and Tapentadol drug interaction - 19 seconds ago
- Amlodipine Besylate and Feeling Hot - 28 seconds ago
- Serax and Fall - 32 seconds ago
- Duloxetine Hydrochloride and Acne Aggravated - 32 seconds ago
- Zoladex and Myopathy - 34 seconds ago
- Tadalafil and Electrolyte Imbalance - 35 seconds ago
- Brilinta and Glivec drug interaction - 40 seconds ago
- Timolol and Anaphylaxis - 56 seconds ago